City

Bethesda (2)

Burlington (1)

Chicago (1)

Eugene (1)

Houston (1)

New York (1)

Palo Alto (1)

Vancouver (1)

Yakima (1)

Condition

B-Cell Leukemia (2)

B-Cell Lymphoma (2)

Acute Lymphoid Leukemia (1)

Leukemia, Lymphocytic, B Cell (1)

Lymphoma, Non-Hodgkin (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

Pharmacyclics LLC. (1)

Collaborator

Intervention

cd19/cd22-car-transduced t cells (1)

cyclophosphamide (1)

fludarabine (1)

pci-32765 (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (1)

NIH (1)

Study Type

Interventional (2)

B-cell Leukemia

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)

Not yet recruiting

Acute Lymphoid Leukemia
+4 more

fludarabine
+2 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Aug 17, 2022

B-Cell Lymphoma, B-Cell Leukemia Trial in United States (PCI-32765)

Completed

B-Cell Lymphoma
B-Cell Leukemia

PCI-32765

Palo Alto, California
+8 more

May 21, 2013